Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2011 Financial Results

NEW BRUNSWICK, N.J., Jan. 17, 2012 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Jan. 24, to discuss fourth-quarter and full-year 2011 financial results.  The meeting will be hosted by William C. Weldon, Chairman of the Board and Chief Executive Officer; Dominic J. Caruso, Vice President, Finance and Chief Financial Officer; and Louise Mehrotra, Vice President, Investor Relations.

Investors and other interested parties may access the broadcast of the live meeting by visiting the Company's website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the meeting concludes at www.investor.jnj.com.      

 

SOURCE Johnson & Johnson

Suggested Articles

At one point, Novartis even offered up $90 apiece for the inclisiran developer but would later say even $85 was too much, a securities filing shows.

Sanofi spent months hyping its Tuesday investor event, and new CEO Paul Hudson certainly laid out a different vision for the drugmaker at the confab.

After more than 10 years as partners, Sanofi and Regeneron are splitting up their deal to comarket PCSK9 med Praluent and immunology drug Kevzara.